In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis A Chan, R Shinde, C C Chow, C S Cockram, R Swaminathan Abstract Objective-To examine whether sodium pump activity plays a part in the pathogenesis of thyrotoxic periodic paralysis.
Design -Measurement of platelet sodium-potassium ATPase and in vivo sodium pump activities in healthy subjects and thyrotoxic subjects with and without paralysis.
Setting-University hospital in Hong Kong. Subjects-21 healthy subjects, 23 untreated thyrotoxic subjects, 13 untreated men with periodic paralysis, seven treated thyrotoxic subjects, and six treated men with periodic paralysis.
Main outcome measures-Platelet Na+, K+-ATPase activity and plasma rubidium concentration after oral loading.
Results-Median (range) platelet Na+, K+-ATPase activity in thyrotoxic subjects was 253 (169-821) [imol inorganic phosphate/h/g proteinsignificantly higher than that in healthy subjects (134 (81-180) [tmoWhIg protein; p<0001). Na', K+-ATPase activity in those with periodic paralysis was 374 (195-1196) [tmol/hIg protein, again significantly higher than that in healthy subjects (p<0-001) and that in other thyrotoxic subjects (p<0-01) despite similar degrees of hyperthyroidism. Activities in treated thyrotoxic subjects with and without periodic paralysis were 148 (110-234) and 131 (86-173) [ The pathogenesis of periodic paralysis is not fully understood. The associated hypokalaemia is believed to be due to a rapid influx of potassium into cells,'" ' as in the familial type. An important factor in the transport of potassium into cells is the sodium pump sodium-potassium ATPase (Na+, K+-ATPase, EC 3.6.1.3). The sodium pump is known to be affected by thyroid status. The number and activity of sodium pumps in muscle'2 and white cells5 13 14 are increased in patients with thyrotoxicosis. In experimental animals given triiodothyronine'5 16 or in cells cultured in vitro in the presence of triiodothyronine'7 18 Na+, K+-ATPase activity is stimulated. The increased entry of potassium into cells in patients with periodic paralysis may result from increased Na+, K+-ATPase activity. In this study we tested this hypothesis by measuring the platelet Na+, K+-ATPase activity in vitro together with in vivo assessment of sodium pump activity.
Subjects and methods
We studied five groups of subjects: healthy subjects who had no known illness and denied taking any drugs; thyrotoxic subjects who were not receiving treatment and who had raised plasma concentrations of free triiodothyronine and thyroxine and lowered thyroid stimulating hormone concentration at the time of the study; thyrotoxic subjects receiving treatment who had clinically and biochemically normal thyroid function; thyrotoxic subjects with periodic paralysis who were admitted to hospital with weakness or paralysis and studied within 48 hours of admission after correction of plasma potassium concentration and muscle weakness but before starting treatment with (3 blockers or antithyroid drugs, or both; and six subjects who had had episodes of periodic paralysis and who were receiving treatment and had clinically normal thyroid function at the time of study.
All studies were carried out with the full informed consent of those concerned and the study was approved by the ethics committee of the Chinese University of Hong Kong.
PLATELET NA +, K+-ATPASE ACTIVITY
The Na+, K+-ATPase activity in platelets was studied in all five groups of subjects: 15 healthy men, 15 untreated thyrotoxic men, seven treated thyrotoxic men, 12 untreated men with periodic paralysis, and six treated men with periodic paralysis. Blood samples were taken from all subjects in the morning, at least three hours after the last meal or after an overnight fast.
The samples were taken into trisodium citrate (9 ml of blood to 1 ml ofcitrate) and heparinised tubes. Citrated blood was used for platelet studies, and plasma from heparinised blood was used for the measurement of electrolyte, creatinine, thyroid hormone, and thyroid stimulating hormone concentrations.
Platelet rich plasma was prepared as described by Table I shows the age and plasma concentrations of free triiodothyronine and thyroxine in the untreated patients with periodic paralysis. subjects with periodic paralysis the platelet Na+, K+-ATPase activity (374 (195-1196) tmol/h/g protein) was higher than that in healthy subjects (p<0001) and that in other thyrotoxic subjects (p<001). In treated thyrotoxic subjects concentrations of free triiodothyronine and thyroxine and platelet Na+, K+-ATPase activity were lower than in untreated subjects. However, platelet Na+, K+-ATPase activity was still significantly higher than that found in healthy controls (p<0 01). In subjects with treated periodic paralysis the platelet Na+, K + -ATPase activity was not different from that of healthy subjects ( *Platelet Na +, K -ATPase activity was measured in all but subject 13. tReference range 3-3-8-2 pmouIl.
TReference range 7-0-21-5 pmoUl.
three groups of subjects. The mean (95% confidence interval) plasma rubidium concentration at five hours in thyrotoxic subjects (7T0 (6-6 to 7 5) [tmol/l) was significantly lower than that in healthy subjects (10-2 (9-5 to [tmol/l, p<0001). In subjects with periodic paralysis the five hour concentration (6 0 ( 5 7 to 6 3) [tmol/1) was significantly lower than that in the thyrotoxic group (p<001). The plasma rubidium concentration at one hour also showed a similar picture (17i0 (14-9 to 19-2), (109 to 11-9), 10-4 (9 7 to [tmol/l in healthy, thyrotoxic, and periodic paralysis groups, respectively).
Discussion
Our results show that Na+, K+-ATPase activity in platelets is increased in thyrotoxic subjects with or without periodic paralysis. Increased numbers of sodium pumps, increased pump activity, and increased Na+, K+-ATPase activity have been shown in lymphocytes5 and in a mixed leucocyte preparation3 from thyrotoxic subjects. Increased ouabain binding capacity has also been shown in human skeletal muscle in hyperthyroidism. 12 The similarity between the changes in platelets and nucleated cells such as leucocytes and muscle cells in hyperthyroidism suggests that platelet Na+, K+-ATPase activity reflects that occurring in other tissues. The use of platelets is advantageous as the preparation is less tedious and requires a smaller volume of blood than is needed with leucocytes.
In a mixed leucocyte preparation Na+, K+-ATPase activity has been reported to be 22% higher in patients with hyperthyroidism.3 In our study platelet Na', K+-ATPase activity in hyperthyroid subjects was nearly double that of healthy subjects. Thus platelet Nat, K+-ATPase may be a useful tissue marker of thyroid status.
The ideal tissue in which to study periodic paralysis is skeletal muscle. However, muscle biopsy is invasive and platelets provide a readily accessible alternative.
We found that the platelet Na+, K+-ATPase activity in untreated subjects with periodic paralysis was 80% higher than that in other untreated thyrotoxic subjects despite similar degrees of hyperthyroidism. In lymphocytes Oh et al were unable to show a significant increase in sodium pump mediated rubidium influx in patients with periodic paralysis, although they suggested that ouabaia binding sites may be increased.5 Other workers have studied erythrocytes to investigate periodic paralysis.724 However, erythrocytes behave differently from other cells in thyroid disease'42527 and are not a suitable cell type to study this condition.
To verify that platelet Na+, K+-ATPase activity measured in vitro reflects the sodium pump activity in vivo, we assessed the in vivo sodium pump activity.
Rubidium is transported into cells by the sodium pump and the transport characteristics of rubidium and potassium are similar.28 The disappearance of rubidium from extracellular fluid therefore depends largely on the sodium pump activity, and the plasma BMJ VOLUME 303concentration of rubidium is inversely related to the sodium pump activity. Skeletal muscle is the largest single tissue in the body. Thus it is likely that the plasma rubidium concentration mirrors skeletal muscle sodium pump activity. The lower plasma concentration of rubidium at one and five hours after an oral load in untreated thyrotoxic subjects shows that the sodium pump activity is increased, and this confirms results from in vitro studies in muscle and leucocytes.2 13 In untreated subjects with periodic paralysis the plasma rubidium concentration was lower, and thus the activity of the sodium pump higher than in thyrotoxic subjects without paralysis. This supports our data from platelets. The observed differences in plasma rubidium concentration between groups could also be due to reduced absorption of rubidium or enhanced clearance by the kidney. However, renal clearance of rubidium is slow and the half life is between 20 and 50 days.29 Thus it is unlikely that the observed differences are due to renal clearance. Rubidium is handled like potassium and it is unlikely that reduced absorption would have contributed to the observed changes. These results therefore indicate that higher Na+, K+-ATPase activity is a feature of thyrotoxic periodic paraalysis and that this enhanced activity may be responsible for the hypokalaemia seen in these patients.
In treated subjects with periodic paralysis the platelet Na+, K+-ATPase activity was similar to that found in healthy subjects, showing that the sodium pump activity returns to normal with treatment. Thus the higher platelet Na+, K+-ATPase activity seen in subjects with periodic paralysis is likely to be due to increased sensitivity to thyroid hormones and is demonstrable only in the presence of hyperthyroidism.
We conclude that platelet Na+, K+-ATPase activity and in vivo sodium pump activity are increased in thyrotoxicosis. These findings agree with those in other tissues in vitro, although the size of the change is greater in platelets than has been reported in leucocytes. In subjects with periodic paralysis both platelet activity and in vivo sodium pump activity are increased to a greater degree than those in other thyrotoxic subjects despite similar increases in thyroid hormone concentrations. The difference between the two groups disappears when a euthyroid state is restored with treatment.
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ONE HUNDRED YEARS AGO
The announcement of the investment of Lady Roberts and certain of the army hospital nurses with the Order of the Red Cross, testifies once more to the strong interest felt by Her Majesty in the welfare of her invalid soldiers and the care of the sick. It were much to be wished that the same lively interest and spontaneous regard for hospital administration were shown by the War Office. At the present moment, if we had to point to a conspicuous example of a highly defective hospital placed under conditions in which it is impossible that the interests of the sick can be properly regarded, we should, we regret to say, have to point to the hospital establishment for the treatment of the soldiers at Aldershot suffering from infectious and contagious diseases. While large sums are being expended on all sides in barracks and mess-rooms, the hospital, which has to provide for this important class of diseases in a camp of some thirteen thousand men, their wives, and children, is so neglected as to its buildings that it is not possible to provide adequate safeguards for the spread of infection from one class of patients to the other. This neglect of an obvious duty to the sick is emphasised by the fine buildings which are arising on the same lines for other purposes, which might have been postponed. The necessity for ameliorating the insanitary and defective structural arrangements now existing, is, we believe, very fully admitted; but for some unknown reason it appears to be indefinitely postponed. Meantime, the mess-rooms flourish while the hospitals suffer.
(BritishMedicalJrournal 1891;ii:958)
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